Press Enter to search · Esc to close
A new review reframes Alzheimer's risk around peripheral insulin resistance — not blood sugar itself — and points to tiny cellular couriers as possible carriers of metabolic damage to the brain.
A new 2,798-person disparities cohort puts the leading Alzheimer's blood test under a fairness lens. The biomarker held up across groups — the single threshold did not.
A small serum study fingers two circulating lipids — nervonic acid and 15-epi-PGA1 — that throttle mitochondria in a dish. It's early, but it reframes Alzheimer's as a whole-body energy problem.
Scientists watching a new fluorescent sensor inside Alzheimer's-model mouse neurons spotted a quieter fuel crisis — and a possible way to refill the tank.